These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 8790412)
1. The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. Scheidler S; Fredericks WJ; Rauscher FJ; Barr FG; Vogt PK Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9805-9. PubMed ID: 8790412 [TBL] [Abstract][Full Text] [Related]
2. A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma. Kempf BE; Vogt PK Cell Growth Differ; 1999 Dec; 10(12):813-8. PubMed ID: 10616906 [TBL] [Abstract][Full Text] [Related]
3. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator. Sublett JE; Jeon IS; Shapiro DN Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639 [TBL] [Abstract][Full Text] [Related]
4. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Fredericks WJ; Galili N; Mukhopadhyay S; Rovera G; Bennicelli J; Barr FG; Rauscher FJ Mol Cell Biol; 1995 Mar; 15(3):1522-35. PubMed ID: 7862145 [TBL] [Abstract][Full Text] [Related]
5. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Bennicelli JL; Edwards RH; Barr FG Proc Natl Acad Sci U S A; 1996 May; 93(11):5455-9. PubMed ID: 8643596 [TBL] [Abstract][Full Text] [Related]
6. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119 [TBL] [Abstract][Full Text] [Related]
7. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro. Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908 [TBL] [Abstract][Full Text] [Related]
8. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene. Fredericks WJ; Ayyanathan K; Herlyn M; Friedman JR; Rauscher FJ Mol Cell Biol; 2000 Jul; 20(14):5019-31. PubMed ID: 10866659 [TBL] [Abstract][Full Text] [Related]
9. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Barr FG Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein. Xia SJ; Barr FG Oncogene; 2004 Sep; 23(41):6864-71. PubMed ID: 15286710 [TBL] [Abstract][Full Text] [Related]
11. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma. Anderson J; Ramsay A; Gould S; Pritchard-Jones K Am J Pathol; 2001 Sep; 159(3):1089-96. PubMed ID: 11549601 [TBL] [Abstract][Full Text] [Related]
12. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Anderson J; Gordon T; McManus A; Mapp T; Gould S; Kelsey A; McDowell H; Pinkerton R; Shipley J; Pritchard-Jones K; Br J Cancer; 2001 Sep; 85(6):831-5. PubMed ID: 11556833 [TBL] [Abstract][Full Text] [Related]
13. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Davis RJ; Barr FG Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8047-51. PubMed ID: 9223312 [TBL] [Abstract][Full Text] [Related]
14. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma. Hu Q; Yuan Y; Wang C PLoS One; 2013; 8(6):e68065. PubMed ID: 23799156 [TBL] [Abstract][Full Text] [Related]
15. The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain. Lam PY; Sublett JE; Hollenbach AD; Roussel MF Mol Cell Biol; 1999 Jan; 19(1):594-601. PubMed ID: 9858583 [TBL] [Abstract][Full Text] [Related]
16. Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoprotein. Xia SJ; Rajput P; Strzelecki DM; Barr FG Lab Invest; 2007 Apr; 87(4):318-25. PubMed ID: 17297479 [TBL] [Abstract][Full Text] [Related]
17. Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma. Rodeberg DA; Nuss RA; Heppelmann CJ; Celis E Cancer Immunol Immunother; 2005 Jun; 54(6):526-34. PubMed ID: 15838707 [TBL] [Abstract][Full Text] [Related]
18. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929 [TBL] [Abstract][Full Text] [Related]
19. Normal and rearranged PAX3 expression in human rhabdomyosarcoma. Frascella E; Toffolatti L; Rosolen A Cancer Genet Cytogenet; 1998 Apr; 102(2):104-9. PubMed ID: 9546061 [TBL] [Abstract][Full Text] [Related]
20. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Barr FG; Nauta LE; Davis RJ; Schäfer BW; Nycum LM; Biegel JA Hum Mol Genet; 1996 Jan; 5(1):15-21. PubMed ID: 8789435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]